KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Inventory Average (2016 - 2025)

Historic Inventory Average for Sarepta Therapeutics (SRPT) over the last 10 years, with Q3 2025 value amounting to $1.0 billion.

  • Sarepta Therapeutics' Inventory Average rose 9693.49% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 9693.49%. This contributed to the annual value of $536.4 million for FY2024, which is 10363.78% up from last year.
  • According to the latest figures from Q3 2025, Sarepta Therapeutics' Inventory Average is $1.0 billion, which was up 9693.49% from $967.7 million recorded in Q2 2025.
  • Over the past 5 years, Sarepta Therapeutics' Inventory Average peaked at $1.0 billion during Q3 2025, and registered a low of $192.6 million during Q1 2022.
  • In the last 5 years, Sarepta Therapeutics' Inventory Average had a median value of $254.5 million in 2021 and averaged $398.8 million.
  • In the last 5 years, Sarepta Therapeutics' Inventory Average tumbled by 2295.98% in 2022 and then skyrocketed by 14288.03% in 2025.
  • Over the past 5 years, Sarepta Therapeutics' Inventory Average (Quarter) stood at $237.3 million in 2021, then dropped by 10.43% to $212.6 million in 2022, then skyrocketed by 33.33% to $283.4 million in 2023, then skyrocketed by 132.13% to $657.9 million in 2024, then soared by 57.4% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q3 2025, $967.7 million for Q2 2025, and $845.7 million during Q1 2025.